NASDAQ: BGNE       Beigene Ltd Ads
Last Price Today's Change   Day's Range   Trading Volume
353.68   -9.12 (2.51%)  350.00 - 371.365  166,282


Avg Volume (4 weeks):346,841
4 Weeks Range:244.09 - 371.365
4 Weeks Price Volatility (%):
52 Weeks Range:118.55 - 371.365
52 Weeks Price Volatility (%):
Average Price Target:-


No recent Headlines for this stock.

Business Background

BeiGene Ltd is a United States based clinical-stage biopharmaceutical company. It is engaged in the discovery and development of molecularly targeted and immuno-oncology drugs for the treatment of cancer. The company has developed a proprietary cancer biology platform that addresses the importance of tumor-immune system interactions and the value of primary biopsies in developing new models to support its drug discovery effort. It has developed clinical-stage drug candidates that inhibit the important oncology targets Bruton's tyrosine kinase, or BTK; RAF dimer protein complex and PARP family of proteins, and an immuno-oncology agent that inhibits the immune checkpoint protein receptor PD-1.

  Be the first to like this.

I3 Messenger
Individual or Group chat with anyone on I3investor

2153  4249  247  3253 

Top 10 Active Counters
 NAKD 0.488+0.052 
 CTRM 0.397+0.072 
 F 11.66+0.80 
 ACST 0.834+0.077 
 BBIG 5.55+4.01 
 LK 1.38+1.38 
 CLSN 1.86+0.585 
 ADTX 4.436+1.826 
 SNDL 0.656-0.025 
 WPX 9.43+0.48